Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK5 | Q00535 | 3/20 | 0.77 |
| ▸ | CDK5R1 | Q15078 | 2/20 | 0.77 |
| ▸ | MEN1 | O00255 | 4/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.71 |
| ▸ | STK17B | O94768 | 4/20 | 0.53 |
| ▸ | RECQL | P46063 | 3/20 | 0.53 |
| ▸ | AURKA | O14965 | 3/20 | 0.53 |
| ▸ | GSK3B | P49841 | 3/20 | 0.53 |
| ▸ | GAA | P10253 | 3/20 | 0.53 |
| ▸ | DAPK3 | O43293 | 2/20 | 0.53 |
| ▸ | BLK | P51451 | 2/20 | 0.53 |
| ▸ | TEK | Q02763 | 2/20 | 0.53 |
| ▸ | BTK | Q06187 | 2/20 | 0.53 |
| ▸ | ITK | Q08881 | 2/20 | 0.53 |
| ▸ | STK17A | Q9UEE5 | 2/20 | 0.53 |
| ▸ | DAPK2 | Q9UIK4 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfurein SCHEMBL29462894 | 1.00 | CDK5 (0.77) | CDK5CDK5R1MEN1KMT2ASTK17B | |
| SCHEMBL29362331 | 0.87 | CDK5 (1.00) | CDK5CDK5R1MEN1KMT2ARECQL | |
| Maritimein SCHEMBL1706306 | 0.83 | MEN1 (1.00) | CDK5CDK5R1MEN1KMT2AGAA | |
| Maritimein SCHEMBL29354648 | 0.83 | MEN1 (1.00) | CDK5CDK5R1MEN1KMT2AGAA | |
| Maritimein SCHEMBL1706313 | 0.83 | MEN1 (1.00) | CDK5CDK5R1MEN1KMT2AGAA | |
| SCHEMBL1043781 | 0.81 | CDK5 (0.80) | CDK5CDK5R1MEN1KMT2ASTK17B | |
| SCHEMBL13324395 | 0.81 | MEN1 (0.66) | CDK5CDK5R1MEN1KMT2ASTK17B | |
| SCHEMBL31360843 | 0.80 | MEN1 (0.81) | CDK5CDK5R1MEN1KMT2AGAA | |
| SCHEMBL1098173 | 0.80 | MEN1 (0.81) | CDK5CDK5R1MEN1KMT2AGAA | |
| Z-Astringin SCHEMBL501245 | 0.74 | POLB (0.81) | CDK5CDK5R1MEN1KMT2ARECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100247464-A1 | COSMETIC COMPOSITION HAVING ANTI-RADICAL PROPERTIES AND CORRESPONDING APPLICATION METHOD | YVES SAINT LAURENT PARFUMS (FR) | 2010-09-30 | — | — | US | claimed |
| US-8475848-B2 | Cosmetic composition having anti-radical properties and corresponding application method | YVES SAINT LAURENT PARFUMS (FR) | 2013-07-02 | — | — | US | disclosed |
| US-20100247464-A1 | COSMETIC COMPOSITION HAVING ANTI-RADICAL PROPERTIES AND CORRESPONDING APPLICATION METHOD | YVES SAINT LAURENT PARFUMS (FR) | 2010-09-30 | — | — | US | disclosed |
| US-20090221690-A1 | Pharmaceutical Composition for the Prevention/Treatment of Bone Disorders and a Process for the Preparation Thereof | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (US) | 2009-09-03 | — | — | US | disclosed |
| EP-1993579-A2 | A PHARMACEUTICAL COMPOSITION FOR THE PREVENTION/TREATMENT OF BONE DISORDERS AND A PROCESS FOR THE PREPARATION THEREOF | Council of Scientific and Industrial Research (IN) | 2008-11-26 | — | — | EP | disclosed |
| WO-2007099432-A2 | PHARMACEUTICAL COMPOSITION CONTAINING BUTEA ISOFLAVONES FOR THE PREVENTION /TREATMENT OF BONE DISORDERS AND A PROCESS FOR THE PREPARATION THEREOF | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2007-09-07 | — | — | WO | disclosed |
| US-20060228313-A1 | Method of cosmetic depigmentation care by applying at least one aurone | COLETICA (FR) | 2006-10-12 | — | — | US | disclosed |
| EP-1709964-A2 | A method of cosmetic depigmentation care by applying at least one aurone | ENGELHARD LYON (FR) | 2006-10-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060228313-A1 | Method of cosmetic depigmentation care by applying at least one aurone | TYR, MITF, MC1R | CDK5 2550/4885CDK5R1 3200/4885MEN1 2351/4885 |
| US-20100247464-A1 | COSMETIC COMPOSITION HAVING ANTI-RADICAL PROPERTIES AND CORRESPONDING APPLICATION METHOD | CUTA, CAT, PRDX3 | CDK5 4009/4885CDK5R1 3921/4885MEN1 4622/4885 |
| US-20090221690-A1 | Pharmaceutical Composition for the Prevention/Treatment of Bone Disorders and a Process for the Preparation Thereof | SOST, BPGM, PTMS | CDK5 673/4885CDK5R1 1290/4885MEN1 197/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.